Brief: Strides Pharma Science June-Quarter Consol Net Profit 702 Mln Rupees
29/07/2024 09:31
July 29 (Reuters) - Strides Pharma Science Ltd
SRID.NS :
* INDIA’S STRIDES PHARMA SCIENCE JUNE-QUARTER CONSOL NET
PROFIT
702 MILLION
* STRIDES PHARMA SCIENCE JUNE-QUARTER CONSOL REVENUE FROM
CONTINUING OPERATIONS 10.88 BILLION RUPEES
Source text for Eikon: ID:
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees